Reykjavik, July 1, 2009.

deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia

Reykjavik, June 29, 2009.

deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis

Reykjavik, June 26, 2009.

deCODE Reinstated to Nasdaq Global Market

Reykjavik, May 20, 2009.

deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation

Reykjavik, May 17, 2009.

deCODE Study Shows Complex Interplay of the Human Biological Clock with Height, Weight and Disease

Reykjavik, May 11, 2009.

deCODE genetics Announces First Quarter 2009 Financial Results

Reykjavik, May 7, 2009.

deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results

Reykjavik, April 28, 2009.

Nasdaq Stays Suspension of Trading in deCODE Stock

Reykjavik, April 23, 2009.

deCODE and Celera Partner to Expand Use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes

Reykjavik, April 15, 2009.

deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes

Reykjavik, March 31, 2009.

deCODE genetics Announces Full-year 2008 Financial Results

Reykjavik, March 26, 2009.

deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results

Reykjavik, February 19, 2009.

deCODE Receives California Clinical Laboratory License

Reykjavik, February 9, 2009.

Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack

Reykjavik, February 6, 2009.

deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Asessment and Earlier Intervention

Reykjavik, February 3, 2009.

deCODEme™ Takes on Heart Disease in February

Reykjavik, February 3, 2009.

deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market

Reykjavik, February 2, 2009.

deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor

Reykjavik, January 20, 2009.

deCODE Sells Auction Rate Securities

Reykjavik, January 18, 2009.

A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer

Reykjavik, January 18, 2009.

Introducing deCODEme Cardio™ and deCODEme Cancer™

Reykjavik, January 16, 2009.

Stories from Our Foremothers: deCODE Publishes an Unparalleled Genetic Snapshot of Iceland 1000 Years Ago